Skip to Content

Yancheng Suhai Pharmaceutical, China, 2024

GMP Audit Report

Company
Yancheng Suhai Pharmaceutical

Product(s)
Doxycyclin Hyclate

Country
China

Audit Year
2024


0.00 € 0.00 €
0.00 €